C. Lovdahl et al., Antisense oligonucleotides to stromelysin mRNA inhibit injury-induced proliferation of arterial smooth muscle cells, HIST HISTOP, 14(4), 1999, pp. 1101-1112
Smooth muscle cell migration and proliferation are important events in the
formation of intimal lesions associated with atherosclerosis and restenosis
following balloon angioplasty. To make this possible, the smooth muscle ce
ll has to change from a contractile to an activated repair cell with capaci
ty to synthesize DNA and extracellular matrix components. There is now cons
iderable evidence that the extracellular matrix has important functions in
modulating the phenotypic properties of smooth muscle cells, but less is kn
own about the role of the matrix metalloproteinases. The present study inve
stigates the role of stromelysin in the modulation of rat aortic smooth mus
cle cell morphology and function following mechanical injury in vitro and i
n vivo. Antisense mRNA oligonucleotides were used to investigate the role o
f stromelysin expression in injury-induced phenotypic modulation and the su
bsequent migration and proliferation of vascular smooth muscle cells. Cultu
red rat aortic smooth muscle cells and balloon-injured rat carotid arteries
were used as experimental models. Light- and electron microscopy were used
to follow changes in smooth muscle cell phenotype and lesion formation and
incorporation of H-3-thymidine to detect DNA synthesis. Injury-induced DNA
synthesis and migration in vitro were inhibited by 72% and 36%, respective
ly, by adding stromelysin antisense oligonucleotides to the medium prior to
injury. In primary cultures, 67% of the smooth muscle cells treated with s
tromelysin antisense were retained in a contractile phenotype as judged by
analysis of cell fine structure, compared to 15% untreated cells and 40% in
cells treated with mismatched oligonucleotides. Examination of the carotid
arteries one week after balloon injury likewise demonstrated a larger frac
tion of contractile cells in the inner parts of the media in vessels treate
d with antisense oligonucleotides compared to those treated with mismatched
oligonucleotides. The neointima was also distinctly thinner in antisense-t
reated than in mismatched-treated and control arteries at this time. These
findings indicate that stromelysin mRNA antisense oligonucleotides inhibite
d phenotypic modulation of rat arterial smooth muscle cells and so caused a
decrease in migration and proliferation and neointima formation in respons
e to vessel wall injury.